Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration
S Shore, EP Carey, MP Turakhia, CA Jackevicius… - American heart …, 2014 - Elsevier
Background Dabigatran is a novel oral anti-coagulant (NOAC) that reduces risk of stroke in
patients with non-valvular atrial fibrillation (NVAF). It does not require routine monitoring with …
patients with non-valvular atrial fibrillation (NVAF). It does not require routine monitoring with …
Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation
S Perreault, S de Denus, B White‐Guay… - … : The Journal of …, 2020 - Wiley Online Library
Background and Purpose Data on oral anticoagulant (OAC) uptake and pattern of use are
limited. Real‐life data in patients with atrial fibrillation (AF) are important for understanding …
limited. Real‐life data in patients with atrial fibrillation (AF) are important for understanding …
Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a F rench nationwide cohort study
G Maura, A Pariente, F Alla… - … and Drug Safety, 2017 - Wiley Online Library
Abstract Purpose Direct oral anticoagulants (DOACs) have been promoted in patients with
nonvalvular atrial fibrillation (nv‐AF) as a more convenient alternative to vitamin K …
nonvalvular atrial fibrillation (nv‐AF) as a more convenient alternative to vitamin K …
Adherence to warfarin treatment among patients with atrial fibrillation
M Skeppholm, L Friberg - Clinical Research in Cardiology, 2014 - Springer
Background Treatment with warfarin greatly reduces the risk of stroke related to atrial
fibrillation, but will not be effective unless patients adhere to treatment. Lack of fixed dosing …
fibrillation, but will not be effective unless patients adhere to treatment. Lack of fixed dosing …
Comparison of treatment persistence with dabigatran or rivaroxaban versus vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a competing risk …
Background Direct oral anticoagulants (DOAC s) have been proposed as a more convenient
alternative to vitamin K antagonists (VKA s), which are commonly associated with poor …
alternative to vitamin K antagonists (VKA s), which are commonly associated with poor …
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation
M Paquette, L Mbuagbaw, A Iorio… - European Heart …, 2021 - academic.oup.com
Aims Reports of long-term oral anticoagulant (OAC) therapy for atrial fibrillation (AF) reveal
highly variable, and generally suboptimal estimates of medication persistence. The objective …
highly variable, and generally suboptimal estimates of medication persistence. The objective …
[引用][C] Part of this chapter is based on
RMF van Schie, TI Verhoef, A de Boer, T Schalekamp… - Towards optimal dosing of …, 2013